Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 5, 2012BloodOpen Access

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

DRDavide RossiOspedale di Santo SpiritoMFMarco FangazioUniversité Libre de BruxellesSRSilvia Rasi

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rossi et al. (2012) studied this question.

synapsesocial.com/papers/69dbe3d5eb8801008ea3c1f9https://doi.org/10.1182/blood-2011-12-395673
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines2008 · 3,808 citations
  2. 2Chronic Lymphocytic Leukemia2005 · 1,687 citations
  3. 3Richter syndrome: molecular insights and clinical perspectives2009 · 122 citations
  4. 4Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome2009 · 226 citations
  5. 5The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation2011 · 381 citations